12 news items
Kevzara® (sarilumab) Approved by FDA for the Treatment of Active Polyarticular Juvenile Idiopathic Arthritis (pJIA)
REGN
11 Jun 24
President, Head, Specialty Care at Sanofi. "This milestone highlights our ongoing commitment to bringing medicines to our younger patients living
MAIA Biotechnology Inc (MAIA) Stock Surges as Company Prepares to Present Promising Data at BIO International Convention
CRL
IQV
MAIA
31 May 24
results.InvestorBrandMedia.com does not commit to updating forward-looking statements based on new information or future events. Readers are encouraged to review all public
Update on FDA Priority Review of Dupixent® (dupilumab) for the Treatment of COPD Patients with Type 2 Inflammation
REGN
31 May 24
that the additional analyses strongly support the approval of Dupixent in COPD with evidence of type 2 inflammation, and are committed to working with the FDA
Press Release: Update on FDA priority review of Dupixent for the treatment of COPD patients with type 2 inflammation
REGN
31 May 24
, and are committed to working with the FDA to bring Dupixent to patients living with uncontrolled COPD as quickly as possible
More than $9 Million Awarded to High School Scientists and Engineers at the Regeneron International Science and Engineering Fair 2024
REGN
17 May 24
organization, Society for Science is committed to inform, educate and inspire. Learn more
y2bjgoveg6s1z832zynfwd4adr1x8hk1rx3ab39zr3o0wnrcqh0h2
REGN
17 May 24
organization, Society for Science is committed to inform, educate and inspire. Learn more
jqv6d8xnp81qldd0qeiwvckhsu3i78 faxibnw5oo1n4bjiqfag
REGN
17 May 24
) membership organization, Society for Science is committed to inform, educate and inspire. Learn more
i1hvgjns65ghshayiofjx
REGN
29 Apr 24
extensive data presentations at ARVO showcase the differentiated efficacy, safety and durability of EYLEA HD, and demonstrate our commitment to advancing
n5hnulxj8kxq2rv3bf1lud5ygbl5i3i96gexqzqy
REGN
24 Apr 24
, M.D., Ph.D., Board co-Chair, President and Chief Scientific Officer at Regeneron. "These latest clinical results build on our ongoing commitment
lzd87nhx9oqhfwafapbnqkq16hfhmmo0j4crv9aws9sr7yyj0vsbxm4sgzwr
ARGX
ATNM
MRNA
28 Mar 24
potential, and commitment to improving patient care that is both rare and invaluable.
Wednesday's biotech sector
kxw ojx6otg4odvryfq0sa1c5qkknbghl4mnqutmk8xmv2
ARGX
ATNM
AZN
26 Mar 24
. Past performance does not guarantee future results.InvestorBrandMedia.com does not commit to updating forward-looking statements based on new
cu5axwnr4tfe0m2yl5dhl6m0hgsfafmzt
REGN
25 Mar 24
and that the timelines to completion be agreed prior to resubmission. Regeneron is committed to working closely with the FDA and investigators to bring odronextamab
- Prev
- 1
- Next